Arlington Capital Partners, a Washington, DC-based private equity firm, has acquired Micron Technologies in partnership with the company’s management team. Headquartered in Malvern, PA, Micron is a provider of particle size engineering and related analytical services. Terms of the acquisition were not disclosed. Greenberg Traurig served as counsel to Arlington for the transaction; Fairmount Partners advised Micron.   “Micron’s ability to provide leading bio-availability solutions across the drug...